EP Validation Quote
Simply send us a list of the European countries you would like to file in and we will send you a European validation quote with a breakdown of translation costs and service fees per country. Click here to request a quote
For more information about European validations, please visit our website.
News
From August 1, 2026, Jersey will be an independent designation under WIPO’s Madrid System.
What changes from August 1, 2026?
Until now, designating the United Kingdom in an international trademark application or in a subsequent designation (“expand protection”) automatically extended protection to Jersey.
From August 1, 2026:
- Designating the UK will no longer cover Jersey. To protect your trademark in Jersey, you will need to select Jersey as a separate designation — in a new international trademark application, a subsequent designation, or when renewing an international trademark registration.
- Jersey will have its own Office of origin. Applicants based in Jersey will file their international trademark applications directly through the Jersey Registrar of Intellectual Property.
What happens to existing registrations?
If your international trademark registration designates the United Kingdom and was recorded before August 1, 2026, here’s what to expect:
- Your registration is protected in the UK on August 1, 2026: You don’t need to take any action. WIPO will automatically record a Jersey designation for your registration. From that point, the Jersey and UK designations will operate independently of each other.
- The UK refusal period has not yet expired: WIPO will only record a Jersey designation once the UK issues a statement of grant of protection or a final decision granting total or partial protection.
- Your registration has been refused or invalidated in the UK: WIPO will not record a designation of Jersey.
***
(ID) In October 2025, the Indonesian Patent Office introduced comprehensive amendments to the Patent Law. The most important change concerns the introduction of a mandatory declaration of use for patents and utility models, which must be paid and submitted with each annuity and at the same time when the respective annuity must be paid.
For all payments already due in 2025 and with due dates up to December 31, 2025, these declarations of use can be submitted by December 31, 2025, whereby a separate declaration of use must be issued for each IP right.
Effective from January 01, 2026, each declaration of use must be paid and submitted in combination with the payment of each respective annuity. If these declarations of use are not being paid and submitted, the IP right, or any licenses granted for it may expire, even if the respective annuity fees will be paid correctly when being due.
For this reason, IPRIS now automatically offers you the service of submitting these declarations of use with each of your annuity payments in Indonesia instructed with us. The respective payment agent-related fees for this service are therefore already included in the annuity fee amounts in our price list. Without the submission of the declaration of use, we are no longer able to offer annuity payments in Indonesia with immediate effect.
IMPORTANT: For all annuity fees due in Indonesia in 2025 that we have already paid on your behalf, we will send you the templates for the declaration of use by email in a timely manner. These must be signed and returned to us by email. A scanned version is sufficient. Exact details will be provided in the corresponding communication. Regardless of this matter, to ensure the future protection of your IP-rights, we recommend that you check your Indonesian IP-portfolio, if all your annuities are duly paid. If you have not received an email from us with the declaration of use, please contact us by December 15, 2025, at the latest.
If you would like us to pay an annuity fee that is still due but has not yet been instructed to pay in 2025, please also contact us by December 15, 2025, at the latest.
Thank you for your understanding and support.
***
Contact Us
General Enquiries
IPRIS Team
[email protected]
+41 (0) 61 270 88 19
Customer Support
IPRIS Team
[email protected]
Certain features of this website are covered by one or more claims of US patents 5,895,468 and 6,182,078

